388 related articles for article (PubMed ID: 36833509)
21. Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates.
Marsillach J; Richter RJ; Costa LG; Furlong CE
Curr Protoc; 2021 Jan; 1(1):e25. PubMed ID: 33484495
[TBL] [Abstract][Full Text] [Related]
22. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides.
Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A
Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme.
Mahrooz A
Curr Clin Pharmacol; 2016; 11(4):259-264. PubMed ID: 27633038
[TBL] [Abstract][Full Text] [Related]
24. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
Bortolasci CC; Vargas HO; Souza-Nogueira A; Gastaldello Moreira E; Vargas Nunes SO; Berk M; Dodd S; Barbosa DS; Maes M
Redox Rep; 2014 Nov; 19(6):232-41. PubMed ID: 25037113
[TBL] [Abstract][Full Text] [Related]
25. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypes.
Huen K; Harley K; Bradman A; Eskenazi B; Holland N
Toxicol Appl Pharmacol; 2010 Apr; 244(2):181-9. PubMed ID: 20045427
[TBL] [Abstract][Full Text] [Related]
28. The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity.
Gaidukov L; Tawfik DS
J Lipid Res; 2007 Jul; 48(7):1637-46. PubMed ID: 17435182
[TBL] [Abstract][Full Text] [Related]
29. The Effects of Anthocyanins and Their Microbial Metabolites on the Expression and Enzyme Activities of Paraoxonase 1, an Important Marker of HDL Function.
Aboufarrag HT; Needs PW; Rimbach G; Kroon PA
Nutrients; 2019 Nov; 11(12):. PubMed ID: 31771252
[TBL] [Abstract][Full Text] [Related]
30. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans.
Taravati A; Ardestani SK; Ziaee AA; Ghorbani A; Soroush MR; Faghihzadeh S; Kazemi H; Rezaei A; Hoseini H; Ghazanfari T
Int Immunopharmacol; 2013 Nov; 17(3):974-9. PubMed ID: 23370296
[TBL] [Abstract][Full Text] [Related]
31. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure.
Hernández AF; Mackness B; Rodrigo L; López O; Pla A; Gil F; Durrington PN; Pena G; Parrón T; Serrano JL; Mackness MI
Hum Exp Toxicol; 2003 Nov; 22(11):565-74. PubMed ID: 14686479
[TBL] [Abstract][Full Text] [Related]
32. Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat.
Nus M; Frances F; Librelotto J; Canales A; Corella D; Sánchez-Montero JM; Sánchez-Muniz FJ
J Nutr; 2007 Jul; 137(7):1783-8. PubMed ID: 17585031
[TBL] [Abstract][Full Text] [Related]
33. The effect of divalent metal chelators and cadmium on serum phosphotriesterase, lactonase and arylesterase activities of paraoxonase 1.
Bizoń A; Milnerowicz H
Environ Toxicol Pharmacol; 2018 Mar; 58():77-83. PubMed ID: 29306821
[TBL] [Abstract][Full Text] [Related]
34. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
[TBL] [Abstract][Full Text] [Related]
35. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
Liu ML; James RW; Ylitalo K; Taskinen MR
Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240
[TBL] [Abstract][Full Text] [Related]
36. Paraoxonase activity and genetic polymorphisms in northern Han Chinese workers exposed to organophosphate pesticides.
Zhang X; Sui H; Li H; Zheng J; Wang F; Li B; Zhang Y
Exp Biol Med (Maywood); 2014 Feb; 239(2):232-9. PubMed ID: 24326413
[TBL] [Abstract][Full Text] [Related]
37. Relationship between the esterase paraoxonase-1 (PON1) and metal concentrations in the whole blood of Inuit in Canada.
Laird BD; Goncharov AB; Ayotte P; Chan HM
Chemosphere; 2015 Feb; 120():479-85. PubMed ID: 25260045
[TBL] [Abstract][Full Text] [Related]
38. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
[TBL] [Abstract][Full Text] [Related]
39. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
[TBL] [Abstract][Full Text] [Related]
40. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
